Hormone Research in Paediatrics Discussion Paper
Response to a Discussion Post
Hi XYZ,
Thank you for a thought provoking discussion on type 1 and 2 diabetes. I like that your perspective on the issue is direct and elaborate. As it stands, about 422 million people have at least one type of diabetes, with 1.5million patients dying yearly (Sadarangani et al., 2021). The disease is the seventh leading cause of death in the United States (Marks et al., 2021); hence, its discussion is becoming increasingly significant. Hormone Research in Paediatrics Discussion Paper
Basically, I like how you’ve linked your post with transitional words and coherent sentences. Importantly, you have supported it with a book and sources from a reliable journal. One thing that stands out for me is the standard and academic English within the post. Although the evidence has strengthened your claims and put forth your points more effectively, I’m afraid that some of your sources might be out-dated. Sources from Papatheodorou et al., (2016) and Papanas et al., (2016) are more than five years old. According to (Sadarangani et al., 2021), one of the key principles of evidence-based practice in nursing is current and solid research. Current research articles are those within the 5-years period lens.
Understandably, I agree with your thoughts on diabetes mellitus complications. To add on to them, the disease can damage a person’s nerves and cause pain and numbness, affecting the heart, blood vessels, and digestive system (Marks et al., 2021). Truly, those who are at risk, especially the elderly, should adopt healthy lifestyle to prolong their quality of life. All in all, I’m open to any addition or criticism on this subject. Hormone Research in Paediatrics Discussion Paper
Thank you.
References
Marks, B. E., Khilnani, A., Meyers, A., Flokas, M. E., Gai, J., Monaghan, M., Streisand, R., & Estrada, E. (2021). Increase in the Diagnosis and Severity of Presentation of Pediatric Type 1 and Type 2 Diabetes during the COVID-19 Pandemic. Hormone research in paediatrics, 94(7-8), 275–284. https://doi.org/10.1159/000519797
Sadarangani, T., Zagorski, W., Parker, L., & Missaelides, L. (2021). Identifying Research Priorities in Adult Day Centers to Support Evidence-Based Care of Vulnerable Older Adults. Progress in community health partnerships : research, education, and action, 15(1), 127–131. https://doi.org/10.1353/cpr.2021.0012 Hormone Research in Paediatrics Discussion Paper
Which test is used to differentiate between type 1 and type 2 diabetes? Type 1 diabetes must be considered in patients of any age or weight who present with a new onset of diabetes and an unclear clinical picture. This is especially true in children, even if they are overweight. HbA1c is not recommended as a diagnostic test for patients with possible or suspected type 1 diabetes for two reasons. Firstly, in type 1 diabetes hyperglycemia can develop rapidly and might not be reflected in the HbA1c level. Secondly, it can take days for a laboratory to measure HbA1c, but glucose samples are usually tested more rapidly (Butler & Misselbrook 2020). What other recommendations, treatments or teaching will you provide for the patients? Patient needs regular follow up for annual eye exam to monitor and evaluate patient for microvascular changes like diabetic retinopathy. Nephrology needs to be consulted if kidney function decline. Podiatry consults are very important as diabetic patients are prone to neuropathy. Skin dryness can lead to wound, gangrenes and amputations. Hypertension and hyperlipidemia needs effective management as patient is risk for atherosclerosis (Papatheodorou et al. 2016). Dietician consults is very vital for patients as diet modifications have direct impact on outcomes and in lowering patient’s HbA1c. Patients should be educated on lifestyle modifications and exercise regimen. What are the complications of type 2 diabetes? The prevalence of diabetes (DM) is constantly increasing worldwide at an alarming rate. According to the International Diabetes Federation in 2015, an estimated 415 million people globally were suffering from this condition. Complications of DM account for increased morbidity, disability, and mortality and represent a threat for the economies of all countries, especially the developing ones (Papatheodorou et al. 2016). Hormone Research in Paediatrics Discussion Paper Thy can be categorized as microvascular complications, macro vascular complications and miscellaneous complications. Diabetic nephropathy, neuropathy, and retinopathy are the main microvascular complications induced by chronic hyperglycemia via several mechanisms such as the production of advanced glycation end products. Atherosclerosis is more common in people with DM than in those without. Diabetic cardiomyopathy is a specific complication that develops independently of coronary artery disease or hypertension and it is possible to lead to increased morbidity and mortality (Papatheodorou et al. 2016). Reference Butler, A. E., & Misselbrook, D. (2020). Distinguishing between type 1 and type 2 diabetes. bmj, 370. Papatheodorou, K., Papanas, N., Banach, M., Papazoglou, D., & Edmonds, M. (2016). Complications of diabetes 2016. Journal of diabetes research, 2016. Hormone Research in Paediatrics Discussion Paper
